55 Comparison of longitudinal change in soluble ST2 versus B-type natriuretic peptide to predict major adverse cardiovascular events in asymptomatic patients in the community
55 Comparison of longitudinal change in soluble ST2 versus B-type natriuretic peptide to predict major adverse cardiovascular events in asymptomatic patients in the community